FDA Watch: Labcorp Gets Companion Diagnostic Approval for Advanced Melanoma Test
Company also announces distribution of newly approved Alzheimer’s assay
Already a member? Log in here
FDA-lir
Subscribe today for access to
Articles and Reports
FDA Watch: OraSure’s Collection Device for Cobas STI Testing Receives Approval
At-home sample collections can be mailed to a clinical laboratory
Already a member? Log in here
FDA Watch: Zepto Life Technology Receives FDA Breakthrough Designation for Blood-Based Mold Test
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
Already a member? Log in here
How Laboratories Are Developing New Coronavirus Diagnostic Tests at Record Speed
...
Already a member? Log in here
Reimbursement: Congress Calls on Insurers to Cover Coronavirus Testing without Charging Patients
...
Already a member? Log in here
Lab industry leaders meet with White House on COVID-19 testing
...
Already a member? Log in here
Two commercial labs testing now for COVID-19
...
Already a member? Log in here
FDA Watch: Agency Finalizes CLIA Waiver Guidance for New IV Devices
...
Already a member? Log in here
FDA Watch: Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
Already a member? Log in here
Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
Already a member? Log in here
Lab Companies Scramble to Bring Coronavirus Detection Tests to Market
...
Already a member? Log in here
FDA Watch: Agency Targets Sale of IVD Reagents without Premarket Approval
...
Already a member? Log in here
FDA Watch: Agency Clears the Way for Approval of Blood-Based PSA Test
The U.S. Preventive Services Task Force (USPTF) recommends that men age 55 to 65 consider prostate cancer screening. The reason it doesn’t directly recommend testing for all men in this age group is that current screening methods that rely on detecting high levels of
Already a member? Log in here